Wednesday, July 11, 2018
Some of the world's biggest drugmakers are canceling or reducing planned price increases in the U.S., after a new California drug-pricing transparency law and continued political pressure over pharmaceutical costs.
This story is only available from the Arkansas Online archives. Stories can be purchased individually for $2.95. Click here to search for this story in the archives.
ArkansasOnline.com for only
$0.99 for the first month.